World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases

Balance Point Completes Closings for Its 8th and 9th Funds, Raising Over $880 Million

WL Writing Staff by WL Writing Staff
December 9, 2025
in Press Releases
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

WESTPORT, Conn., Dec. 9, 2025 /PRNewswire/ — Balance Point Capital Advisors, LLC (“Balance Point”) is pleased to announce the closing of its two latest funds Balance Point Capital Partners VI, L.P. and Balance Point Capital Partners VII, L.P.


Balance Point Capital Partners, LP. (PRNewsfoto/Balance Point Capital Partners,)

Together, the funds represent over $880 million of total capital, strengthening Balance Point’s position as a leading private credit platform in the U.S. lower middle market (“U.S. LMM”). With $2.3 billion in assets under management, Balance Point is well-positioned to continue delivering flexible debt and equity capital solutions to the U.S. LMM.1

Funds VI and VII reflect a continuation of the same investment strategy Balance Point has consistently executed throughout its history. Balance Point’s investment strategy seeks to capitalize on structural inefficiencies within the U.S. LMM. We remain focused on partnering with sponsors and management teams and investing primarily in asset-light businesses that have scalable cost structures, low recurring capital investing needs and meaningful financial performance visibility.

“We’re proud of the success of our recent fundraising efforts,” said Balance Point Managing Partner, Seth Alvord. “To have closed two funds in what has been a difficult fundraising environment is an achievement that speaks to the power of our platform and the continued support of our valued partners.”

With 17 years of experience, and more than 100 debt and equity investments, our team brings together deep experience in underwriting and executing investments across a variety of industries and through various economic cycles. The recent closings of BPCP VI and BPCP VII, further reinforce the strength of our platform, and will help to propel us forward in the years to come.

About Balance Point Capital

Balance Point is an alternative investment manager focused on the lower middle market. With approximately $2.3 billion in assets under management, Balance Point invests debt and equity capital in select lower middle market companies across a variety of investment vehicles. Balance Point takes a long-term, partnership approach to investing and is committed to building lasting relationships with its partners, management teams and intermediaries. Balance Point is a registered investment adviser. Further information is available at www.balancepointcapital.com.

1 As of September 30, 2025. Assets under management is calculated as the sum of (i) the total asset value determined in accordance with GAAP, (ii) unfunded commitments, and (iii) undrawn committed or assumed SBA leverage, where applicable.

Media Contact: 
Adam H. Sauerteig
Office: 203-652-8555
asauerteig@balancepointcapital.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/balance-point-completes-closings-for-its-8th-and-9th-funds-raising-over-880-million-302636795.html

SOURCE Balance Point Capital

WL Writing Staff

WL Writing Staff

Related Posts

KEURIG DR PEPPER WORKERS IN GEORGIA TO HOLD RALLY

April 30, 2026

Elite Robots Launches RoboBarista to Revolutionize Self-Service Coffee Experiences in Commercial and Public Spaces

April 30, 2026

GIGABYTE Wins Red Dot Design Award Across Its AI Product Lineup

April 30, 2026

Huawei Launches Xinghe AI Network Security Agentic SOC to Build Next-Generation Autonomous Intelligent Security Operations

April 30, 2026

UVARA Jewelry Expands OEM/ODM Services for Global Brands

April 30, 2026

D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types

April 30, 2026

Popular News

  • Elite Robots Launches RoboBarista to Revolutionize Self-Service Coffee Experiences in Commercial and Public Spaces

    0 shares
    Share 0 Tweet 0
  • KEURIG DR PEPPER WORKERS IN GEORGIA TO HOLD RALLY

    0 shares
    Share 0 Tweet 0
  • GIGABYTE Wins Red Dot Design Award Across Its AI Product Lineup

    0 shares
    Share 0 Tweet 0
  • Huawei Launches Xinghe AI Network Security Agentic SOC to Build Next-Generation Autonomous Intelligent Security Operations

    0 shares
    Share 0 Tweet 0
  • D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler